✦ LIBER ✦

Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant

✍ Scribed by F. Torre; F. Mattioli; N. Campo; A. Delfino; M. Basso; N. Pelli; A. Martelli; A. Picciotto

Book ID: 119227764
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 128 KB
Volume: 36
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2004.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics of lamivudine-resistant HBV mut

Dynamics of lamivudine-resistant HBV mutants: a quasispecies analysis

✍ Coralie Pallier; Laurent Castera; Alexandre Soulier; Daniel Dhumeaux; Jean-Miche 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Quantification of the relative levels of

Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray

✍ Z. G. Li; L. Y. Chen; J. Huang; P. Qiao; J. M. Qiu; S. Q. Wang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Use of Inno-Lipa HBV-DR to assess the se

Use of Inno-Lipa HBV-DR to assess the sensitivity of lamivudine-resistant HBV mutants to adefovir

✍ Vincent Thibault; Yves Benhamou; Olivier Lada; Fabienne Mousnier; Marie Bochet; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Prolonged Persistence of Lamivudine-resi

Prolonged Persistence of Lamivudine-resistant Mutant and Emergence of New Lamivudine-resistant Mutants Two Years After Lamivudine Withdrawal in HBsAg-positive Chronic Hepatitis Patient: A Case Report

✍ R. Orlando; G. Tosone; G. Portella; E. Veropalumbo; M. D’Onofrio; M. Piazza 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 193 KB

Fulminant hepatitis B due to a lamivudin

Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV

✍ Maurizio Bonacini; Alan Kurz; Stephen Locarnini; Anna Ayres; Craig Gibbs 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Serum HBV RNA is a predictor of early em

Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine

✍ Tsuyoshi Hatakeyama; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Lamivudine (LAM) is a nucleoside analogue widely used for the treatment of chronic hepatitis B virus (HBV) infection. Emergence of resistant strains with amino acid substitutions in the tyrosine-methionine-aspartate-aspartate (YMDD) motif of reverse transcriptase is a serious problem in patients on